Connecticut 2017 2017 Regular Session

Connecticut House Bill HB06149 Introduced / Bill

Filed 01/19/2017

                    General Assembly  Proposed Bill No. 6149
January Session, 2017  LCO No. 1003
 *01003*
Referred to Committee on GENERAL LAW
Introduced by:
REP. RILEY, 46th Dist.

General Assembly

Proposed Bill No. 6149 

January Session, 2017

LCO No. 1003

*01003*

Referred to Committee on GENERAL LAW 

Introduced by:

REP. RILEY, 46th Dist.

AN ACT CONCERNING CANNABIDIOL PRESCRIPTION MEDICATION.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That the general statutes be amended to specify that, if a cannabidiol investigational product is newly approved as a prescription medication by the federal Food and Drug Administration and rescheduled by the federal Drug Enforcement Administration, such investigational product shall be similarly approved as a prescription medication in this state.

Statement of Purpose: 

To provide a potential treatment for children and adults with epilepsy.